Project opportunity
This Earmarked Scholarship project is aligned with a recently awarded Category 1 research grant. It offers you the opportunity to work with leading researchers and contribute to large projects of national significance.
CRE-RESPOND, an NHMRC Centre of Research Excellence, aims to address antimicrobial resistance and the associated unacceptably poor outcomes for neonatal and paediatric patients. We aim to achieve this by applying an evidence-based personalised antimicrobial dosing approach involving pre-clinical translational studies and tailored clinical studies. The research program includes the following four main workstreams:
- Clinical dosing studies: This workstream involves several projects on pharmacokinetic (PK) dosing evaluation of antimicrobial in special patient populations in critically ill neonatal and paediatric patients
- Bioanalytical method development: This workstream involves designing novel bioanalytical methods suitable for using microsampling for therapeutic drug monitoring
- Design of optimal dosing strategies: Advanced mechanism-based mathematical modelling will be applied to design optimal regimens that maximise patient outcomes while minimising the emergence of antimicrobial resistance. Data generated from the clinical pharmacokinetics studies and using bioanalytical methods will be used in this workstream.
We are keen to take a PhD candidate for this project under the above workstreams.
Applicants from diverse backgrounds including pharmacy, medicine, pharmacology, nursing, biomedical science, microbiology, and pharmaceutical sciences are strongly encouraged to apply.
Knowledge of pharmacokinetics, LC-MSMS, ELISA, and pharmacometrics, is highly desirable for each workstream, respectively.
Scholarship value
As a scholarship recipient, you'll receive:
- living stipend of $32,192 per annum tax free (2023 rate), indexed annually
- tuition fees covered
- single Overseas Student Health Cover (OSHC)
This PhD is supported by an annual top-up scholarship of $12,000 per annum, above the current stipend.
Supervisor
Faculty of Medicine
Email: j.roberts2@uq.edu.au
Preferred educational background
Your application will be assessed on a competitive basis.
We take into account your
- previous academic record
- publication record
- honours and awards
- employment history.
A working knowledge of pharmacokinetics, LC-MSMS, ELISA, and pharmacometrics would be of benefit to someone working on this project.
The applicant will demonstrate academic achievement in the field(s) of pharmacy, medicine, pharmacology, nursing, biomedical science, microbiology, and pharmaceutical sciences and the potential for scholastic success.
A background or knowledge of pharmacokinetics, LC-MSMS, ELISA, and pharmacometrics, is highly desirable for each workstream, respectively.
Latest commencement date
If you are the successful candidate, you must commence by Research Quarter 1, 2025. You should apply at least 3 months prior to the research quarter commencement date.
If you are an international applicant, you may need to apply much earlier for visa requirements.
How to apply
You apply for this project as part of your PhD program application.